We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Neos Therapeutics Inc | NASDAQ:NEOS | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.15 | 1.10 | 1.11 | 0 | 01:00:00 |
From May 2019 to May 2024
Lundin Law PC (http://lundinlawpc.com/) announces that it is investigating claims against Neos Therapeutics, Inc. (“Neos” or the “Company”) (Nasdaq: NEOS) concerning possible violations of federal securities laws.
To get more information about this investigation, please contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via email at brian@lundinlawpc.com.
The investigation focuses on the Company’s August 11, 2016 announcement of its financial results for the second quarter of 2016, reporting that Neos missed its earnings expectations by $0.49 per share. When this news was announced, the Neos stock price fell.
Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160930005758/en/
Lundin Law PCBrian Lundin, Esq.Telephone: 888-713-1033Facsimile: 888-713-1125brian@lundinlawpc.comhttp://lundinlawpc.com/
1 Year Neos Therapeutics Chart |
1 Month Neos Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
